The Potential of a Small Melanocytic Lesion to Transform into Choroidal Melanoma: A Retrospective Study and Literature Review

Author:

Garcia-Caride Sara1,Formoso Laura2,Maciñeira Elia De Esteban2,Silva-Rodriguez Paula3,Pardo Maria4,Bande Manuel F2,Blanco-Teijeiro María Jose2

Affiliation:

1. Hospital Povisa

2. University Hospital of Santiago de Compostela

3. Fundación Pública Galega de Medicina Xenómica, Clinica University Hospital of Santiago de Compostela, Santiago de Compostela,

4. Grupo Obesidómica, Instituto de Investigación Sanitaria de Santiago (IDIS), CIBEROBN, ISCIII, Santiago de Compostela, 15706, Spain

Abstract

Abstract Purpose This research aimed to identify critical risk factors for the malignant transformation of small melanocytic choroidal lesions (SMCL) Methods A retrospective longitudinal study was conducted on 218 SMCL cases at the University Hospital of Santiago de Compostela from January 2013 to January 2023. Patients were selected based on their diagnosis of SMCL and their undergoing of comprehensive multimodal imaging such as optical coherence tomography, ultrasonography, and fundus autofluorescence. The primary focus was on evaluating demographic data, symptomatic presentations, and detailed imaging features. Results The cohort consisted of 43% males and 57% females, with a mean age of 69 years. Notably, 19% of the lesions were symptomatic, and 25.5% exhibited orange pigment. Approximately 33% of the tumours were proximate to the optic disc. Multivariate analysis revealed orange pigment presence and a lesion height greater than 2 mm as significant predictors of transformation. The Cox and Snell R-squared coefficient of 0.292 indicated that these factors accounted for about 29.2% of the variability in lesion transformation. The average follow-up period was 52 months, during which 4.6% of the SMCLs evolved into CM. Conclusion This study highlights the substantial role of lesion height exceeding 2 mm and the presence of orange pigment as key risk factors for the transformation of SMCL into CM. These findings are instrumental in aiding clinicians to identify and monitor high-risk patients, enabling early and potentially more effective interventions. Future research is essential to further explore these risk factors and to establish a more comprehensive understanding of SMCL progression to CM.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3